8. What Separates Drug from the Poison Flashcards

1
Q

Selectivity

A

THE MOST IMPORTANT ATTRIBUTE THAT
SEPARATES THE DRUG FROM THE
POISON…BUT NOT ALL DRUGS HAVE
THIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

death from cold damp Northern climates comes mainly from

A

respiratory infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

death from hot southern climates come from

A

gut infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

1993 infectious diseases accounted for ____of deaths in developed world and ____ of deaths in developing world

A

1.2% & 41.5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tuberculosis

A
  • Has killed more than 1 billion people
  • Developed resistance to antibiotics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drug sensitive TB

A

*Requires 6 months of treatment
*Cure rate 85%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Multi-drug resistant TB
(2017: 580,000 new cases)

A

*Requires 18 months of treatment
*Cure rate 48%
*14,000 pills and injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Extensively drug resistant TB
(2017: 50,000 cases)

A

*Cure rate 34% (much less in some studies)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When dealing with bacteria __________ is not difficult, ___________ is our main concern

A
  1. selectivity
  2. permeability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Tuberculosis cell wall have a barrier with the consistency of ….

A

candle wax at room temperature (therefore needs assistance from our silicon-based drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

A.I. and machine-learning hare helpful to identify:

A
  • Compounds which will be active against bacterial targets
  • Compounds which will penetrate bacterial cell walls
  • Compounds as clever as those we stumbled on accidentally taking advantage of unusual opportunities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mycobacterial KatG

A

This is technically a poison but since it is in the bacterium (not in the location of the human cell), it can not effect human cells because we do not have this enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Small changes can be the difference between a drug and poison that is why we need

A

a crystal structure to guide what we are doing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GPCR receptors

A

the most common class of drug target

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The biggest challenge for drug development

A

metabolic stability and the liver
- The liver contains enzymes called cytochrome P450s (CYP450s) which often oxidize drugs into an inactive
analogue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

We must find and rule out every_______ in order to make sure the drug will work

A

metabolite

17
Q

Usually want drug to remain effective
for at least _______(for convenience)

A

8 hours

18
Q

Bioavailability (looking for about 50%):

A

How much of the drug will distribute through the body
cardiotoxicity, mutagenicity, general non-specific toxicity
(“cytotoxicity”)

19
Q

penicillin has a _____ therapeutic window thus, has _____ side effects

A

large

low

20
Q

cytotoxic cancer drugs have a ______ therapeutic window and come with _______ effects

A

small

high/ likely adverse

21
Q

Drugs must dissolve in the ____ in order to be absorbed

A

gut

22
Q

_____ and ______ drugs are better at dissolving in the digestive tract

A

Polar and Charged

23
Q

lipophilic

A

tending to combine/ dissolve in lipids or fats.

24
Q

______ drugs are better at passing through biological membranes

A

Lipophilic

25
Q

A poision

A

a non selective drug

26
Q

The drug binding pocket of a GOOD drug target will be a mixture of which characteristics?

A

Enclosed, with a mixture of polar and lipophilic spaces

27
Q

Which of the following is a reason that we usually try to increase the potency of a drug during its development?

A

We hope it will improve the selectivity